X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.biospace.com/article/releases/french-authorities-approve-national-reimbursement-of-orkambi-lumacaftor-ivacaftor-for-eligible-people-ages-two-and-older-with-cystic-fibrosis/?s=89
https://endpts.com/vertex-deal-for-scotland-no-deal-for-england/
https://www.fiercepharma.com/pharma/new-ads-britain-tout-cooperative-approach-to-valuing-drugs-despite-nhs-pushback
http://www.pmlive.com/pharma_news/orkambi_buyers_club_set_up_to_gain_access_to_cheaper_versions_1289916
http://www.pmlive.com/pharma_news/still_no_breakthrough_on_orkambi_talks,_mps_want_answers_1289016
http://www.pmlive.com/pharma_news/optimism_on_orkambi_in_england_as_talks_to_resume_1281226
https://www.biopharmadive.com/news/abbvie-takes-over-cystic-fibrosis-drugs-from-galapagos/540685/
Market Place
Share 
